• Je něco špatně v tomto záznamu ?

Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry

J. Oldgren, JS. Healey, M. Ezekowitz, P. Commerford, A. Avezum, P. Pais, J. Zhu, P. Jansky, A. Sigamani, CA. Morillo, L. Liu, A. Damasceno, A. Grinvalds, J. Nakamya, PA. Reilly, K. Keltai, IC. Van Gelder, AH. Yusufali, E. Watanabe, L. Wallentin,...

. 2014 ; 129 (15) : 1568-76.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14063755

BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia; however, little is known about patients in a primary care setting from high-, middle-, and low-income countries. METHODS AND RESULTS: This prospective registry enrolled patients presenting to an emergency department with AF at 164 sites in 46 countries representing all inhabited continents. Patient characteristics were compared among 9 major geographic regions. Between September 2008 and April 2011, 15,400 patients were enrolled. The average age was 65.9, standard deviation 14.8 years, ranging from 57.2, standard deviation 18.8 years in Africa, to 70.1, standard deviation 13.4 years in North America, P<0.001. Hypertension was globally the most common risk factor for AF, ranging in prevalence from 41.6% in India to 80.7% in Eastern Europe, P<0.001. Rheumatic heart disease was present in only 2.2% of North American patients, in comparison with 21.5% in Africa and 31.5% in India, P<0.001. The use of oral anticoagulation among patients with a CHADS2 score of ≥2 was greatest in North America (65.7%) but was only 11.2% in China, P<0.001. The mean time in the therapeutic range was 62.4% in Western Europe, 50.9% in North America, but only between 32% and 40% in India, China, Southeast Asia, and Africa, P<0.001. CONCLUSIONS: There is a large global variation in age, risk factors, concomitant diseases, and treatment of AF among regions. Improving outcomes globally requires an understanding of this variation and the conduct of research focused on AF associated with different underlying conditions and treatment of AF and predisposing conditions in different socioeconomic settings.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14063755
003      
CZ-PrNML
005      
20140708102349.0
007      
ta
008      
140704s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCULATIONAHA.113.005451 $2 doi
035    __
$a (PubMed)24463370
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Oldgren, Jonas $u Uppsala Clinical Research Center and Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden (J.O., L.W.); Population Health Research Institute, Hamilton, Ontario, Canada (J.S.H., C.A.M., A.G., J.N., S.J.C., S.Y.); Jefferson Medical College, Wynnewood, PA, and Cardiovascular Research Foundation, New York, NY (M.E.); Department of Medicine, University of Cape Town, Cape Town, South Africa (P.C.); Instituto Dante Pazzanesse de Cardiologia, Sao Paulo, Brazil (A.A.); St. John's Medical College, Bangalore, India (P.P., A.S.); Cardiovascular Institute and Fuwai Hospital, Beijing, China (J.Z., L.L.); University Hospital Motol, Prague, Czech Republic (P.J.); Eduardo Mondlane University, Maputo, Mozambique (A.D.); Boehringer-Ingelheim, Ridgefield, CT (P.A.R.); Semmelweis University, Budapest, Hungary (K.K.); Thoraxcenter, University of Groningen, University Medical Center Groningen, the Netherlands (I.C.V.G.); Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates (A.F.Y.); and Department of Cardiology, Fujita Health University School of Medicine, Toyoake, Japan (E.W.).
245    10
$a Variations in cause and management of atrial fibrillation in a prospective registry of 15,400 emergency department patients in 46 countries: the RE-LY Atrial Fibrillation Registry / $c J. Oldgren, JS. Healey, M. Ezekowitz, P. Commerford, A. Avezum, P. Pais, J. Zhu, P. Jansky, A. Sigamani, CA. Morillo, L. Liu, A. Damasceno, A. Grinvalds, J. Nakamya, PA. Reilly, K. Keltai, IC. Van Gelder, AH. Yusufali, E. Watanabe, L. Wallentin, SJ. Connolly, S. Yusuf, . ,
520    9_
$a BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia; however, little is known about patients in a primary care setting from high-, middle-, and low-income countries. METHODS AND RESULTS: This prospective registry enrolled patients presenting to an emergency department with AF at 164 sites in 46 countries representing all inhabited continents. Patient characteristics were compared among 9 major geographic regions. Between September 2008 and April 2011, 15,400 patients were enrolled. The average age was 65.9, standard deviation 14.8 years, ranging from 57.2, standard deviation 18.8 years in Africa, to 70.1, standard deviation 13.4 years in North America, P<0.001. Hypertension was globally the most common risk factor for AF, ranging in prevalence from 41.6% in India to 80.7% in Eastern Europe, P<0.001. Rheumatic heart disease was present in only 2.2% of North American patients, in comparison with 21.5% in Africa and 31.5% in India, P<0.001. The use of oral anticoagulation among patients with a CHADS2 score of ≥2 was greatest in North America (65.7%) but was only 11.2% in China, P<0.001. The mean time in the therapeutic range was 62.4% in Western Europe, 50.9% in North America, but only between 32% and 40% in India, China, Southeast Asia, and Africa, P<0.001. CONCLUSIONS: There is a large global variation in age, risk factors, concomitant diseases, and treatment of AF among regions. Improving outcomes globally requires an understanding of this variation and the conduct of research focused on AF associated with different underlying conditions and treatment of AF and predisposing conditions in different socioeconomic settings.
650    _2
$a akutní nemoc $7 D000208
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    _2
$a fibrilace síní $x farmakoterapie $x epidemiologie $7 D001281
650    _2
$a urgentní služby nemocnice $x statistika a číselné údaje $7 D004636
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x epidemiologie $7 D006973
650    _2
$a internacionalita $7 D038622
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    _2
$a revmatická karditida $x epidemiologie $7 D012214
650    _2
$a hodnocení rizik $7 D018570
650    _2
$a rizikové faktory $7 D012307
650    _2
$a socioekonomické faktory $7 D012959
650    12
$a celosvětové zdraví $7 D014943
651    _2
$a Asie $x epidemiologie $7 D001208
651    _2
$a Severní Amerika $x epidemiologie $7 D009656
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Healey, Jeff S
700    1_
$a Ezekowitz, Michael
700    1_
$a Commerford, Patrick
700    1_
$a Avezum, Alvaro $7 gn_A_00010338
700    1_
$a Pais, Prem
700    1_
$a Zhu, Jun
700    1_
$a Jansky, Petr
700    1_
$a Sigamani, Alben
700    1_
$a Morillo, Carlos A
700    1_
$a Liu, Lisheng
700    1_
$a Damasceno, Albertino
700    1_
$a Grinvalds, Alex
700    1_
$a Nakamya, Juliet
700    1_
$a Reilly, Paul A
700    1_
$a Keltai, Katalin
700    1_
$a Van Gelder, Isabelle C
700    1_
$a Yusufali, Afzal Hussein
700    1_
$a Watanabe, Eiichi
700    1_
$a Wallentin, Lars
700    1_
$a Connolly, Stuart J
700    1_
$a Yusuf, Salim
700    1_
$a ,
773    0_
$w MED00001091 $t Circulation $x 1524-4539 $g Roč. 129, č. 15 (2014), s. 1568-76
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24463370 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140708102639 $b ABA008
999    __
$a ok $b bmc $g 1031239 $s 862487
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 129 $c 15 $d 1568-76 $i 1524-4539 $m Circulation (New York, N.Y.) $n Circulation (New York) $x MED00001091
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Možnosti archivace